עברית

Prof. Arnon Afek

Baruch Ivcher School of Psychology

  • Prof. Arnon Afek is the Associate Director General, the Acting Director of Sheba General Hospital and Chairman of the Department of Medical Administration at Sheba Medical Center. He assumed these positions after completing his tenure as Director General (DG) and Associate Medical DG of the Israeli Ministry of Health (2014-17). At the MoH, Prof Afek led the reforms in Mental Care, the regulation of Cannabis for medical use and public transparency in publishing the outcomes of hospitals "Quality Indicators".

  • Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, Derazne E, Tzur D, Shamis A, Vinker S, Rudich A. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011 Apr 7;364(14):1315-25. doi: 10.1056/NEJMoa1006992. PMID: 21470009; PMCID: PMC4939259.


    Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E, Chaiter Y, Shohat T, Skorecki K, Calderon-Margalit R. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end- stage renal disease. JAMA. 2011 Aug 17;306(7):729-36. doi: 10.1001/jama.2011.1141. PMID: 21846854.


    Eidelman L, Afek A. Israel-Gaza conflict. Lancet. 2014 Aug 23;384(9944):e32-3. doi: 10.1016/S0140-6736(14)61313-1. Epub 2014 Aug 14. PMID: 25132505.

     


    Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E, Ben-Ami Shor D, Tzur D, Afek A, Shamiss A, Haklai Z, Kark JD. Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood. N Engl J Med. 2016 Jun 23;374(25):2430-40. doi: 10.1056/NEJMoa1503840. Epub 2016 Apr 13. PMID: 27074389.


    Balicer RD, Afek A. Digital health nation: Israel's global big data innovation hub. Lancet. 2017 Jun 24;389(10088):2451-2453. doi: 10.1016/S0140-6736(17)30876-0. Epub 2017 May 8. PMID: 28495105.


    Clarfield AM, Manor O, Nun GB, Shvarts S, Azzam ZS, Afek A, Basis F, Israeli A. Health and health care in Israel: an introduction. Lancet. 2017 Jun 24;389(10088):2503-2513. doi: 10.1016/S0140-6736(17)30636-0. Epub 2017 May 8. PMID: 28495109.


    Calderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, Skorecki K, Vivante A. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. N Engl J Med. 2018 Feb 1;378(5):428-438. doi: 10.1056/NEJMoa1700993. PMID: 29385364.


    Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18. PMID: 33610193; PMCID: PMC7906709.


    Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply. Lancet. 2021 Jun 12;397(10291):2249-2250. doi: 10.1016/S0140-6736(21)01059-X. PMID: 34119061; PMCID: PMC8192094.


    Regev-Yochay G, Amit S, Bergwerk M, Lipsitch M, Leshem E, Kahn R, Lustig Y, Cohen C, Doolman R, Ziv A, Novikov I, Rubin C, Gimpelevich I, Huppert A, Rahav G, Afek A, Kreiss Y. Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel. Lancet Reg Health Eur. 2021 Aug;7:100150. doi: 10.1016/j.lanepe.2021.100150. Epub 2021 Jul 7. PMID: 34250518; PMCID: PMC8261633.


    Shavit R, Maoz-Segal R, Iancovici-Kidon M, Offengenden I, Haj Yahia S, Machnes Maayan D, Lifshitz-Tunitsky Y, Niznik S, Frizinsky S, Deutch M, Elbaz E, Genaim H, Rahav G, Levy I, Belkin A, Regev-Yochay G, Afek A, Agmon-Levin N. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open. 2021 Aug 2;4(8):e2122255. doi: 10.1001/jamanetworkopen.2021.22255. PMID: 34463744; PMCID: PMC8408666.